Innovation Pharmaceuticals Inc (IPIX)

[Cognition]

Too funny! Remember when IPIX stopped the K trial early and claimed victory and the naysayers went on a crazy bashing spree. The bashers haven’t a clue what’s going on behind the scene!

“The main takeaways from the meeting were twofold. In order to enter into a development deal with them we needed to show p53 modulation in the tumor and develop a Kevetrin formulation as an oral dose. In our Phase 2a trial in ovarian cancer, intra-tumor p53 modulation was observed.”